Celltrion | 068270 - Current Liabilities

Stock Price
242,500.00
Daily Change
500.00 0.21%
Monthly
12.79%
Yearly
36.24%
Q1 Forecast
232,247.40

Celltrion reported KRW4.01T in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 133.38M 14.66M Sep/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Celltrion KRW 4.01T 343.96B Sep/2025
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.36B 230.7M Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025